Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
AI In Medical Devices Market Poised To Hit $42.43 Billion By 2030 With A 27.3% CAGR
The AI in medical devices market has experienced significant expansion recently. It is projected to increase from $12.38 billion in 2025 to $16.16 billion by 2026, at a compound annual growth rate (CAGR) of 30.5%. Historically, this market’s expansion has been driven by progress in medical device technology, the increasing prevalence of chronic diseases, wider integration of digital health solutions, enhanced healthcare automation, and the need for precise diagnostics.
The AI in medical devices market is projected to experience significant expansion over the coming years. It is expected to reach a valuation of $42.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 27.3%. The drivers behind this growth within the forecast period encompass the integration of AI into clinical workflows, increasing investment in smart healthcare infrastructure, a growing demand for personalized treatment options, the expansion of remote patient monitoring capabilities, and an increase in regulatory approvals for AI-powered devices. Notable trends for this period include AI-enabled diagnostic tools, intelligent surgical assistance systems, predictive patient monitoring devices, smart wearable medical devices, and the integration of clinical decision support.
Get A Free Sample Report With In-Depth Market Insights:
AI In Medical Devices Market Expansion Drivers: What’s Shaping Future Growth?
The future expansion of the AI in medical devices market is anticipated due to the increasing need for personalized medicine. This tailored healthcare method, known as personalized medicine, considers specific patient characteristics such as genetics, environmental influences, and lifestyle choices to improve the efficacy and results of treatments. Several elements fuel the rising requirement for personalized medicine, among them breakthroughs in genomics, greater patient autonomy, and more effective treatments. Artificial intelligence (AI) processes vast amounts of patient data, encompassing genetic details, past medical records, and lifestyle aspects, to construct a thorough picture of individual profiles, thereby enabling customized treatment strategies. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 novel personalized therapies for rare disease patients in 2023, a significant rise from six in 2022. Consequently, the escalating need for personalized medicine acts as a key driver for the expansion of the AI in medical devices market.
AI In Medical Devices Market Segments: Where Is Growth Concentrated?
The AI in medical devices market covered in this report is segmented –
1) By Offerings: Hardware, Software, Services
2) By Technology: Context Awareness, Deep learning, Machine learning, Natural Language Processing, Predictive Analytics, Other Technologies
3) By Deployment: Cloud, On-Premise
4) By Application: Patient care, Treatment, Diagnosis And Monitoring, Other Applications
5) By End-User: Hospitals And Healthcare Providers, Patients, Pharmaceuticals And Biotechnology Companies, Healthcare Payers, Other End Users
Subsegments:
1) By Hardware: Imaging Devices, Wearable Devices, Surgical Robots, Monitoring Devices, Diagnostic Equipment
2) By Software: Imaging Software, Data Analytics Software, Clinical Decision Support Software, Patient Management Software, Workflow Automation Software
3) By Services: Consulting Services, Maintenance And Support Services, Training Services, Integration Services, Managed Services
AI In Medical Devices Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the AI in medical devices market are concentrating on forging strategic collaborations to hasten the integration of AI into the healthcare system and secure a competitive advantage. These alliances are designed to utilize AI’s potential to enhance drug discovery, design, and development processes, as well as to improve the efficiency of medical device manufacturing and lessen risks through machine learning applications. For instance, in March 2023, Medtronic, an Ireland-based medical device company, entered a partnership with NVIDIA Corporation, a US-based software company, with the goal of establishing an AI platform for medical devices. Via this collaboration, the firms intend to embed NVIDIA’s healthcare and edge AI technology into the Medtronic GI Genius intelligent endoscopy module, which was developed and manufactured by Cosmo Pharmaceuticals. GI Genius, the first FDA-approved AI-assisted colonoscopy tool, empowers doctors to identify polyps that have the potential to evolve into colorectal cancer. Ultimately, this strategic partnership seeks to accelerate AI development in healthcare and introduce innovative AI-powered solutions to patient care.
AI In Medical Devices Market Key Participants And Competitive Landscape
Major companies operating in the AI in medical devices market are General Electric Company; Medtronic plc; Siemens Healthineers AG; Nvidia Corporation; Intel Corporation; International Business Machines Corporation; Koninklijke Philips N.V.; Enlitic Inc.; Cloudmedx Inc.; Oncora Medical Inc.; Path AI Inc.; Aidoc Medical Ltd.; Accuray Incorporated; AliveCor; Arterys Inc.; Augmedics Inc.; Brainomix Ltd.; Butterfly Network Inc.; Canon Medical Systems Corporation; CureMetrix Inc.
View The Full AI In Medical Devices Market Report:
AI In Medical Devices Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the AI in medical devices market in 2025. The regions covered in the AI in medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
